Prism Health Diagnostics

Prism Health Diagnostics is a U.S.-based clinical diagnostics company and laboratory operating under the name PrismHealthDx, focused on biomarker-driven testing and wellness monitoring. The company has described its business as delivering biomarker data to primary-care physicians and consumers to support ongoing health management and more informed clinical decisions. Publicly available evidence indicates that it has offered diagnostic laboratory services from Austin, Texas and entered commercial diagnostic partnerships, including an agreement to offer GlycoMark for diabetes management and a U.S. license arrangement around Proteomics International’s PromarkerD test for diabetic kidney disease. The company appears to be a healthcare diagnostics business rather than a therapeutics developer, so traditional drug pipeline, target, and clinical-stage fields are largely not applicable.